Thoratec seeks expanded approval for heart assist pump
This article was originally published in Clinica
Thoratec Laboratories has asked the US FDA to expand approval of its heart-assist pump to include support for heart-surgery patients. The VAD system is currently the only heart-pump approved in the US for use in the left, right or both sides of the heart in patients waiting for transplants. Most devices are approved only for left-ventricular support, by far the biggest market of the three.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.